Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This approach uses smaller doses to support appetite regulation and metabolic function while reducing the chance of unwanted side effects
Evidence-Based Innovator: Ozempic protocols at the medical spa reflect current clinical literature, FDA-approved indications, and evolving best practices for GLP1 use, prioritizing medical appropriateness over trend-driven weight-loss offerings
A quarter, or 25.3%, of adults with diabetes aged 18 to 34 reported using a GLP-1 drug, while the adoption rate was 20.8% among those 65 and older
Insurance Coverage: Some insurance plans covered Mounjaro for diabetes but not Zepbound for weight loss, leading doctors to prescribe Mounjaro off-label
Total Store (All departments), Dollar and Unit % Change vs YA, Latest 52 weeks ending September 28, 2024 Nielsen IQ RO-4970198 LRC-1125
US$ 20.59
US$ 28.18
US$ 26.38
US$ 28.95
US$ 28.61
US$ 26.35
US$ 25.00
